ALGN
Price
$216.87
Change
+$1.52 (+0.71%)
Updated
Dec 6, 6:59 PM EST
55 days until earnings call
DHR
Price
$220.83
Change
+$1.24 (+0.56%)
Updated
Dec 6, 6:59 PM EST
54 days until earnings call
Ad is loading...

ALGN vs DHR ᐉ Comparison: Which is Better to Invest?

Header iconALGN vs DHR Comparison
Open Charts ALGN vs DHRBanner chart's image
Align Technology
Price$216.87
Change+$1.52 (+0.71%)
Volume$331.33K
CapitalizationN/A
Danaher
Price$220.83
Change+$1.24 (+0.56%)
Volume$585.49K
CapitalizationN/A
View a ticker or compare two or three
ALGN vs DHR Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ALGN vs. DHR commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongBuy and DHR is a StrongBuy.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (ALGN: $216.76 vs. DHR: $220.76)
Brand notoriety: ALGN: Notable vs. DHR: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 55% vs. DHR: 56%
Market capitalization -- ALGN: $16.6B vs. DHR: $162.56B
ALGN [@Medical Specialties] is valued at $16.6B. DHR’s [@Medical Specialties] market capitalization is $162.56B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 1 FA rating(s) are green whileDHR’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 1 green, 4 red.
  • DHR’s FA Score: 1 green, 4 red.
According to our system of comparison, DHR is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while DHR’s TA Score has 6 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 3 bearish.
  • DHR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DHR is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Medical Specialties) experienced а +0.13% price change this week, while DHR (@Medical Specialties) price change was -0.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.69%. For the same industry, the average monthly price growth was +9.61%, and the average quarterly price growth was -10.57%.

Reported Earning Dates

ALGN is expected to report earnings on Jan 31, 2024.

DHR is expected to report earnings on Jan 30, 2024.

Industries' Descriptions

@Medical Specialties (+1.69% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ALGN with price predictions.
OPEN
A.I.dvisor published
a Summary for DHR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DHR($163B) has a higher market cap than ALGN($16.6B). ALGN has higher P/E ratio than DHR: ALGN (45.45) vs DHR (27.62). ALGN YTD gains are higher at: 2.779 vs. DHR (-5.812). DHR has higher annual earnings (EBITDA): 9.29B vs. ALGN (738M). DHR has more cash in the bank: 12.3B vs. ALGN (1.28B). ALGN has less debt than DHR: ALGN (127M) vs DHR (22.1B). DHR has higher revenues than ALGN: DHR (29.6B) vs ALGN (3.81B).
ALGNDHRALGN / DHR
Capitalization16.6B163B10%
EBITDA738M9.29B8%
Gain YTD2.779-5.812-48%
P/E Ratio45.4527.62165%
Revenue3.81B29.6B13%
Total Cash1.28B12.3B10%
Total Debt127M22.1B1%
FUNDAMENTALS RATINGS
ALGN vs DHR: Fundamental Ratings
ALGN
DHR
OUTLOOK RATING
1..100
1523
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10018
SMR RATING
1..100
7364
PRICE GROWTH RATING
1..100
6148
P/E GROWTH RATING
1..100
1953
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (81) in the Medical Specialties industry is in the same range as DHR (87). This means that ALGN’s stock grew similarly to DHR’s over the last 12 months.

DHR's Profit vs Risk Rating (18) in the Medical Specialties industry is significantly better than the same rating for ALGN (100). This means that DHR’s stock grew significantly faster than ALGN’s over the last 12 months.

DHR's SMR Rating (64) in the Medical Specialties industry is in the same range as ALGN (73). This means that DHR’s stock grew similarly to ALGN’s over the last 12 months.

DHR's Price Growth Rating (48) in the Medical Specialties industry is in the same range as ALGN (61). This means that DHR’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's P/E Growth Rating (19) in the Medical Specialties industry is somewhat better than the same rating for DHR (53). This means that ALGN’s stock grew somewhat faster than DHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNDHR
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
62%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
58%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 7 days ago
61%
Declines
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
55%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
59%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACB0.490.01
+2.71%
Aurora Cannabis
GATX110.98-0.33
-0.30%
GATX Corp
HLN8.12-0.07
-0.85%
Haleon plc
PSHG2.15-0.03
-1.38%
Performance Shipping
MNKD3.59-0.13
-3.37%
MannKind Corp